Overexpression of the immunoreceptor CD300F has a neuroprotective role in a model of acute brain injury

Brain Pathology

Volumn 22, Issue 3, 2012, Pages 318-328

  Peluffo, Hugo ^a,b   Alí Ruiz, Daniela ^a,b   Ejarque Ortíz, Aroa ^c,f   Heras Alvarez, Victor ^c,f   Comas Casellas, Emma ^c,f   Martínez Barriocanal, Agueda ^c,f   Kamaid, Andres ^a,h   Alvarez Errico, Damiana ^g   Negro, Maria Luciana ^a,b   Lago, Natalia ^b   Schwartz Jr , Simó ^c,f   Villaverde, Antonio ^d,e,f   Sayós, Joan ^c,f  

^a DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^b INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d Institute for Biotechnology and Biomedicine   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^f BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^g UNIVERSITY OF BARCELONA   (Spain)

^h UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Excitotoxicity; Inflammation; Microglia; Neuroprotection; Nonviral gene therapy; Oligodendrocyte

Indexed keywords

CLUSTER OF DIFFERENTIATION 300F IMMUNORECEPTOR; IMMUNOGLOBULIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN CELL; BRAIN INJURY; CELL SURFACE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROGLIA; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PROTEIN EXPRESSION; RAT; WHITE MATTER;

ANIMALS; ASTROCYTES; BRAIN; BRAIN INJURIES; CELLS, CULTURED; HUMANS; MICROGLIA; NEURONS; OLIGODENDROGLIA; RATS; RECEPTORS, IMMUNOLOGIC;

EID: 84859806234     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2011.00537.x     Document Type: Article

References (38)

1. Aguilar H, Alvarez-Errico D, Garcia-Montero AC, Orfao A, Sayos J, Lopez-Botet M (2004) Molecular characterization of a novel immune receptor restricted to the monocytic lineage. J Immunol 173:6703-6711. (Pubitemid 39541055)
2. Alvarez-Errico D, Aguilar H, Kitzig F, Brckalo T, Sayos J, Lopez-Botet M (2004) IREM-1 is a novel inhibitory receptor expressed by myeloid cells. Eur J Immunol 34:3690-3701. (Pubitemid 40012187)
3. Alvarez-Errico D, Sayos J, Lopez-Botet M (2007) The IREM-1 (CD300f) inhibitory receptor associates with the p85alpha subunit of phosphoinositide 3-kinase. J Immunol 178:808-816. (Pubitemid 46095153)
4. Aris A, Villaverde A (2003) Engineering nuclear localization signals in modular protein vehicles for gene therapy. Biochem Biophys Res Commun 304:625-631. (Pubitemid 36513532)
5. Bachelet I, Munitz A, Moretta A, Moretta L, Levi-Schaffer F (2005) The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J Immunol 175:7989-7995. (Pubitemid 41798360)
6. Barclay AN, Wright GJ, Brooke G, Brown MH (2002) CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol 23:285-290. (Pubitemid 34628770)
7. Cameron JS, Alexopoulou L, Sloane JA, DiBernardo AB, Ma Y, Kosaras B et al (2007) Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci 27:13033-13041. (Pubitemid 350159595)
8. Cantoni C, Bottino C, Augugliaro R, Morelli L, Marcenaro E, Castriconi R et al (1999) Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol 29:3148-3159. (Pubitemid 29484205)
9. Carson MJ, Thrash JC, Walter B (2006) The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci Res 6:237-245. (Pubitemid 44849175)
10. Cassina P, Peluffo H, Pehar M, Martinez-Palma L, Ressia A, Beckman JS et al (2002) Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis. J Neurosci Res 67:21-29.
11. Castillo-Ruiz MM, Campuzano O, Acarin L, Castellano B, Gonzalez B (2007) Delayed neurodegeneration and early astrogliosis after excitotoxicity to the aged brain. Exp Gerontol 42:343-354. (Pubitemid 46371354)
12. Clark GJ, Ju X, Azlan M, Tate C, Ding Y, Hart DN (2009) The CD300 molecules regulate monocyte and dendritic cell functions. Immunobiology 214:730-736.
13. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M et al (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28:41-51.
14. Griffiths MR, Gasque P, Neal JW (2010) The regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: a brief review. Int J Inflam 2010:151097.
15. Izawa K, Kitaura J, Yamanishi Y, Matsuoka T, Kaitani A, Sugiuchi M et al (2009) An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRgamma in mast cells. J Immunol 183:925-936.
16. Jackson DG, Hart DN, Starling G, Bell JI (1992) Molecular cloning of a novel member of the immunoglobulin gene superfamily homologous to the polymeric immunoglobulin receptor. Eur J Immunol 22:1157-1163.
17. Kiialainen A, Hovanes K, Paloneva J, Kopra O, Peltonen L (2005) Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS. Neurobiol Dis 18:314-322. (Pubitemid 40431115)
18. Lanier LL (2009) DAP10- and DAP12-associated receptors in innate immunity. Immunol Rev 227:150-160.
19. Long EO (2008) Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol Rev 224:70-84.
20. Ma Y, Li J, Chiu I, Wang Y, Sloane JA, Lu J et al (2006) Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol 175:209-215. (Pubitemid 44631415)
21. Martinez-Barriocanal A, Sayos J (2006) Molecular and functional characterization of CD300b, a new activating immunoglobulin receptor able to transduce signals through two different pathways. J Immunol 177:2819-2830. (Pubitemid 44277797)
22. Martinez-Barriocanal A, Comas-Casellas E, Schwarzt SJ, Martín M, Sayós J (2010) CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation. J Biol Chem 285:41781-41794.
23. Martinez-Palma L, Pehar M, Cassina P, Peluffo H, Castellanos R, Anesetti G et al (2003) Involvement of nitric oxide on kainate-induced toxicity in oligodendrocyte precursors. Neurotox Res 5:399-406.
24. Masocha W (2009) Systemic lipopolysaccharide (LPS)-induced microglial activation results in different temporal reduction of CD200 and CD200 receptor gene expression in the brain. J Neuroimmunol 214:78-82.
25. Munitz A, Bachelet I, Eliashar R, Moretta A, Moretta L, Levi-Schaffer F (2006) The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 107:1996-2003. (Pubitemid 43289383)
26. Neumann H, Takahashi K (2007) Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J Neuroimmunol 184:92-99. (Pubitemid 46365993)
27. Nolte MA, van Olffen RW, van Gisbergen KP, van Lier RA (2009) Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev 229:216-231.
28. Peluffo H, Aris A, Acarin L, Gonzalez B, Villaverde A, Castellano B (2003) Nonviral gene delivery to the central nervous system based on a novel integrin-targeting multifunctional protein. Hum Gene Ther 14:1215-1223. (Pubitemid 37034571)
29. Peluffo H, Acarin L, Aris A, Gonzalez P, Villaverde A, Castellano B, Gonzalez B (2006) Neuroprotection from NMDA excitotoxic lesion by Cu/Zn superoxide dismutase gene delivery to the postnatal rat brain by a modular protein vector. BMC Neurosci 7:35.
30. Peluffo H, González P, Arís A, Acarin L, Villaverde A, Castellano B, González B (2007) RGD domains neuroprotect the immature brain by a glial dependent mechanism. Ann Neurol 62:251-256.
31. Piccio L, Buonsanti C, Mariani M, Cella M, Gilfillan S, Cross AH et al (2007) Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 37:1290-1301. (Pubitemid 46927833)
32. Rothman SM, Olney JW(1995) Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci 18:57-58.
33. Saneto RP, DeVellis J (1987) Neuronal and glial cells: cell culture of the central nervous system. In: Neurochemistry: A Practical Approach. AJ Turner, HS Brachelard (eds), pp. 27-63. IRL Press: Washington, DC.
34. Schmid CD, Sautkulis LN, Danielson PE, Cooper J, Hasel KW, Hilbush BS et al (2002) Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J Neurochem 83:1309-1320. (Pubitemid 35477470)
35. Speckman RA, Wright Daw JA, Helms C, Duan S, Cao L, Taillon-Miller P et al (2003) Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility. Hum Genet 112:34-41. (Pubitemid 36869113)
36. Veillette A, Latour S, Davidson D (2002) Negative regulation of immunoreceptor signaling. Annu Rev Immunol 20:669-707. (Pubitemid 34293437)
37. Webb M, Barclay AN (1984) Localisation of the MRC OX-2 glycoprotein on the surfaces of neurones. J Neurochem 43:1061-1067. (Pubitemid 14011262)
38. Xi H, Katschke KJ Jr, Helmy KY, Wark PA, Kljavin N, Clark H et al (2010) Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1. J Exp Med 207:7-16.